Browse studies, page 1144
Page 1144 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia The Journal of antimicrobial chemotherapy, 2022
- BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections Nature communications, 2024
- Comparison the cost-efficacy of furazolidone-based versus clarithromycin-based quadruple therapy in initial treatment of Helicobacter pylori infection in a variable clarithromycin drug-resistant region, a single-center, prospective, randomized, open-label study Medicine, 2019
- Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study Helicobacter, 2022
- Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients undergoing cataract surgery: the iPERME study European journal of clinical pharmacology, 2020
- Efficacy and Safety of PL-5 (Peceleganan) Spray for Wound Infections: A Phase IIb Randomized Clinical Trial Annals of surgery, 2023
- Keverprazan, a novel potassium-competitive acid blocker: Multiple oral doses safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects Clinical and translational science, 2023
- Pharmacokinetics of levofloxacin in non-lactating goats and evaluation of drug effects on resistance in coliform rectal flora Research in veterinary science, 2020
- Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial The Lancet. Infectious diseases, 2026
- Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections Scientific reports, 2024
- Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial Helicobacter, 2025
- Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018
- Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022
- Analysis of the drug therapy of gatifloxacin and levofloxacin in the treatment of acute bacterial conjunctivitis Pakistan journal of pharmaceutical sciences, 2018
- Evaluation of efficacy and safety of Lacticaseibacillus rhamnosus LRa05 in the eradication of Helicobacter pylori: a randomized, double-blind, placebo-controlled trial Frontiers in immunology, 2024
- Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial The Lancet. Infectious diseases, 2025
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial JAMA, 2018
- Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022
- Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis The New England journal of medicine, 2025
- Six months therapy for tuberculous meningitis The Cochrane database of systematic reviews, 2016
- SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19 The Cochrane database of systematic reviews, 2021
- Real-world use of ceftolozane/tazobactam: a systematic literature review Antimicrobial resistance and infection control, 2021
- Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications Clinical therapeutics, 2015
- Analysis of the assessment of antimicrobial susceptibility. Non-typhoid Salmonella in meat and meat products as model (systematic review) BMC microbiology, 2021
- d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018
- Managing community acquired pneumonia in the elderly - the next generation of pharmacotherapy on the horizon Expert opinion on pharmacotherapy, 2017
- Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates The Indian journal of medical research, 2017
- Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review The Journal of antimicrobial chemotherapy, 2020
- Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients The Journal of antimicrobial chemotherapy, 2019
- Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review BMC public health, 2023
- Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review Clinical drug investigation, 2023
- A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges Antimicrobial agents and chemotherapy, 2020
- A systematic review on maternal-to-infant transfer of drugs through breast milk during the treatment of malaria, tuberculosis, and neglected tropical diseases PLoS neglected tropical diseases, 2023
- Intensified Antituberculosis Therapy Regimen Containing Higher Dose Rifampin for Tuberculous Meningitis: A Systematic Review and Meta-Analysis Frontiers in medicine, 2022
- Updated antimicrobial dosing recommendations for obese patients Antimicrobial agents and chemotherapy, 2024
- Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia European respiratory review : an official journal of the European Respiratory Society, 2023
- Prescribing Cascades: An Umbrella Review and Updated Systematic Review Drugs & aging, 2026
- Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review International journal of antimicrobial agents, 2019
- Antibiotics for community-acquired pneumonia in adult outpatients The Cochrane database of systematic reviews, 2014
- Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis Current opinion in infectious diseases, 2023
- Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review PloS one, 2019
- Preclinical models to optimize treatment of tuberculous meningitis - A systematic review Tuberculosis (Edinburgh, Scotland), 2020
- A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis BMJ (Clinical research ed.), 2009
- Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence Antimicrobial agents and chemotherapy, 2017
- Antibiotics for ventilator-associated pneumonia The Cochrane database of systematic reviews, 2016
- Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis The European respiratory journal, 2023
- Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis PloS one, 2021
- Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections Pharmaceutical research, 2022
- First-line Eradication of Helicobacter pylori Infection with High-Dose Amoxicillin and Vonoprazan: A Systematic Review and Meta-analysis The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2025
- Minocycline in the eradication of Helicobacter pylori infection: A systematic review and meta-analysis World journal of gastroenterology, 2024
- Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis Antimicrobial agents and chemotherapy, 2025
- Continuous versus intermittent infusion of β-lactams in patients with sepsis and septic shock: a systematic review and meta-analysis BMC infectious diseases, 2025
- Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022
- Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2024
- Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis Microbial pathogenesis, 2022
- A comparison of different antibiotic regimens for the treatment of infective endocarditis The Cochrane database of systematic reviews, 2020
- Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review Helicobacter, 2024
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis Wiener klinische Wochenschrift, 2010
- Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day? Presse medicale (Paris, France : 1983), 2000
- A comparison of different antibiotic regimens for the treatment of infective endocarditis The Cochrane database of systematic reviews, 2016
- Levofloxacin adverse effects, data from clinical trials and pharmacovigilance Therapie, 2001
- Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children: A meta-analysis Medicine, 2020
- Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line World journal of gastroenterology, 2012
- Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis Drugs, 2017
- Antimicrobial therapy for chronic bacterial prostatitis The Cochrane database of systematic reviews, 2013
- Primary antibiotic resistance in Helicobacter pylori in China: a systematic review and meta-analysis Journal of global antimicrobial resistance, 2023
- Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis The Journal of antimicrobial chemotherapy, 2010
- Fluoroquinolones for treating tuberculosis (presumed drug-sensitive) The Cochrane database of systematic reviews, 2013
- Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients European Respiratory Journal, 2019
- Application of fluoroquinolone pharmacodynamics Journal of Antimicrobial Chemotherapy, 2000
- Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model Journal of Antimicrobial Chemotherapy, 2006
- Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae The American Journal of Medicine, 2001
- Pharmacodynamic Analysis of Ceftriaxone, Gatifloxacin, and Levofloxacin Against Streptococcus pneumoniae with the Use of Monte Carlo Simulation Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 2005
- ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model Journal of Antimicrobial Chemotherapy, 2004
- Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae : Report from the Antimicrobial Resistance Rate Epidemiology Study Team Antimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin at 750 Milligrams and Various Doses of Metronidazole in Healthy Adult Subjects Antimicrobial Agents and Chemotherapy, 2004
- Mutant Prevention Concentration-Based Pharmacokinetic/Pharmacodynamic Indices as Dosing Targets for Suppressing the Enrichment of Levofloxacin-Resistant Subpopulations of Staphylococcus aureus Antimicrobial Agents and Chemotherapy, 2011
- Pharmacodynamics of Trovafloxacin and Levofloxacin against Bacteroides fragilis in an In Vitro Pharmacodynamic Model Antimicrobial Agents and Chemotherapy, 2002
- Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae Diagnostic Microbiology and Infectious Disease, 2002
- Pharmacodynamics of Levofloxacin against Pseudomonas aeruginosa with Reduced Susceptibility Due to Different Efflux Pumps: Do Elevated MICs Always Predict Reduced In Vivo Efficacy? Antimicrobial Agents and Chemotherapy, 2006
- Pharmacodynamic Modeling of the Evolution of Levofloxacin Resistance in Staphylococcus aureus Antimicrobial Agents and Chemotherapy, 2005
- Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus Journal of Antimicrobial Chemotherapy, 2008
- Pharmacodynamically Guided Levofloxacin Dosing for Pediatric Community-Acquired Pneumonia Journal of the Pediatric Infectious Diseases Society, 2016
- Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy, 2001
- Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy, 1999
- Pharmacokinetics and Pharmacodynamics of Levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in Human Skin Blister Fluid Antimicrobial Agents and Chemotherapy, 2000
- Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema ClinicalTrials.gov · COMPLETED, 2026
- Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis ClinicalTrials.gov · COMPLETED, 2007
- A Placebo and Active-Comparator Controlled Multiple-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of MK-4618 in Patients With Overactive Bladder ClinicalTrials.gov · TERMINATED, 2013
- Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP) ClinicalTrials.gov · COMPLETED, 2015
- Prospective, Randomized, Blinded Phase II Pharmacokinetic/Pharmacodynamic Study of the Efficacy and Tolerability of Levofloxacin in Combination With Optimized Background Regimen for the Treatment of MDR-TB ClinicalTrials.gov · COMPLETED, 2022
- Population Pharmacokinetics and Pharmacodynamics Modeling to Optimize Dosage Regimen of Levofloxacin ClinicalTrials.gov · COMPLETED, 2014
- Urinary Bactericidal Activity of 4 Doses of Levofloxacin (250, 500, &750, and 1000 mg) Against Fluoroquinolone-Resistant E. Coli ClinicalTrials.gov · COMPLETED, 2006
- Comparison between the antimicrobial activity of colistin and ceftazidime-avibactam against multidrug-resistant Pseudomonas aeruginosa isolated from patients with ventilator-associated pneumonia in intensive care units of Kasr Al-Ainy hospitals BMC infectious diseases, 2026
- Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats Biological & pharmaceutical bulletin, 2007
- The pharmacokinetics (PK) / pharmacodynamics (PD) of pretomanid, delamanid and bedaquiline in the BALB/c mouse model of central nervous system tuberculosis BMC infectious diseases, 2026
- Genomic phylogeny, taxonomic classification, genetic landscape, and antibiotic resistance of clinical Stenotrophomonas isolates Frontiers in microbiology, 2026
- Cefiderocol in Children with Hematologic Malignancies-The Multicenter Retrospective Experience of the Infection Working Group of the Italian Pediatric Hematology and Oncology Association (AIEOP) Journal of clinical medicine, 2026
- Evaluation of lung epithelial lining fluid concentrations of lascufloxacin against Streptococcus pneumoniae in a hollow-fiber infection model The Journal of antibiotics, 2025
- An Antimicrobial susceptibility study to compare the in vitro activity of antimicrobial agents in the Philippines against Enterobacterales and Pseudomonas aeruginosa from different infection sites: results from ATLAS surveillance program (2018-2021) BMC infectious diseases, 2026
